ClearPoint Neuro, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4M | $5.7M | $4.6M | $3.6M | $3.9M | $5.1M | $3.8M | $2.7M |
| Cost of Revenue | $2.9M | $2.6M | $2.0M | $1.9M | $1.4M | $555.7K | $656.4K | $16.3K |
| Gross Profit | $4.5M | $3.1M | $2.6M | $1.7M | $2.5M | $4.5M | $3.2M | $2.7M |
| Gross Margin | 60.7% | 54.0% | 56.7% | 46.5% | 63.8% | 89.0% | 82.8% | 99.4% |
| Operating Expenses | ||||||||
| Research & Development | $2.8M | $2.6M | $2.0M | $3.3M | $2.9M | $2.5M | $4.3M | $5.7M |
| SG&A Expense | $4.0M | $4.2M | $8.4M | $8.0M | $7.1M | $6.0M | $4.8M | $4.7M |
| Operating Income | $-6.3M | $-7.5M | $-9.0M | $-5.3M | $-7.5M | $-3.1M | $-5.9M | $-9.5M |
| Operating Margin | -85.9% | -130.3% | -195.3% | -147.6% | -190.2% | -61.9% | -155.1% | -356.5% |
| Interest Expense | $872.9K | $1.1M | $1.3M | $1.0M | $499.8K | $2.6M | $2.5M | $1.6M |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | $0 | $0 | $0 | — | — |
| Net Income | $-7.2M | $-8.1M | $-8.4M | $-4.5M | $-7.1M | $-5.9M | $-8.3M | $-9.5M |
| Net Margin | -97.1% | -140.4% | -183.9% | -125.5% | -180.3% | -116.2% | -217.7% | -354.2% |
| EPS (Basic) | $-0.93 | $-2.93 | $-4.48 | $-0.08 | $-0.12 | $-0.15 | $-0.52 | $-1.40 |
| EPS (Diluted) | $-0.93 | $-2.93 | $-4.48 | $-0.08 | $-0.12 | $-0.15 | $-0.52 | $-1.40 |
| Shares Outstanding (Basic) | 10.7M | 3.6M | 2.3M | 74.8M | 58.5M | 48.1M | 16.1M | — |
| Shares Outstanding (Diluted) | 10.7M | 3.6M | 2.3M | 74.8M | 58.5M | 48.1M | 16.1M | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |